Affinage

DCP1B

mRNA-decapping enzyme 1B · UniProt Q8IZD4

Length
617 aa
Mass
67.7 kDa
Annotated
2026-06-09
16 papers in source corpus 5 papers cited in narrative 5 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 5/5 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

DCP1B is a paralog-specific cofactor of the mRNA decapping enzyme DCP2 that controls the turnover of distinct subsets of cytoplasmic mRNAs (PMID:39485278, PMID:39256052). Its EVH1 domain enhances the mRNA-binding affinity of DCP2, and loss of DCP1B produces transcriptome and metabolome changes distinct from those caused by loss of its paralog DCP1a, establishing non-redundant regulation of endogenous targets (PMID:39485278). Functionally, DCP1B is distinguished from DCP1a by its unique role in coupling the decapping complex to protein-degradation and translational machinery, whereas DCP1a drives decapping-complex assembly and interactions with cap-binding proteins (PMID:39256052). DCP1B localizes to cytoplasmic processing bodies that concentrate RNA decay machinery (PMID:39196777). Within a regulatory program, p53 transcriptionally activates DCP1B, which promotes MAPK4 mRNA turnover to lower MAPK4 protein, thereby suppressing PI3K-independent AKT phosphorylation and restraining NSCLC cell growth and migration (PMID:40200093).

Mechanistic history

Synthesis pass · year-by-year structured walk · 5 steps
  1. 2024 High

    Establishing that DCP1B is not a redundant copy of DCP1a but a distinct decapping cofactor answered whether the two paralogs serve separable functions in mRNA turnover.

    Evidence Reciprocal functional dissection of DCP1a and DCP1b by knockdown/knockout, decapping-complex interaction assays, and mRNA turnover analysis

    PMID:39256052

    Open questions at the time
    • The specific protein-degradation and translational machinery components engaged by DCP1B are not enumerated
    • Which mRNA features dictate DCP1B versus DCP1a target selectivity is unresolved
  2. 2024 High

    Defining the EVH1 domain's biochemical contribution and mapping paralog-specific endogenous consequences clarified how DCP1B mechanistically supports DCP2 and shapes cellular state.

    Evidence DCP1a/DCP1b knockout cell lines with transcriptomics, metabolomics, and biochemical EVH1 domain functional assays

    PMID:39485278

    Open questions at the time
    • Structural basis for how the EVH1 domain enhances DCP2 mRNA-binding affinity is not resolved
    • Direct endogenous mRNA substrates of DCP1B were not individually identified
  3. 2024 Medium

    Imaging placed DCP1B within P-bodies and linked its compartment to viral RNA fate, addressing where DCP1B acts and how its decay environment is remodeled during infection.

    Evidence Single-molecule RNA FISH and co-localization of DCP1b with flaviviral sfRNAs during West Nile, Zika, and dengue infection

    PMID:39196777

    Open questions at the time
    • Single primary method (smRNA-FISH) from one lab
    • Whether DCP1B directly catalyzes or recruits machinery for sfRNA decay is not demonstrated
  4. 2025 Medium

    Connecting DCP1B to a p53-driven program answered how its decapping activity is regulated transcriptionally and translated into a tumor-suppressive signaling outcome.

    Evidence p53 transcriptional activation assays, DCP1B perturbation, MAPK4 mRNA decay assays, AKT phosphorylation readouts, and in vitro/in vivo NSCLC proliferation assays

    PMID:40200093

    Open questions at the time
    • No independent replication of the p53–DCP1B–MAPK4 axis
    • Whether MAPK4 mRNA is a direct DCP1B/DCP2 decapping substrate is not biochemically established
  5. 2023 Low

    A proximity-labeling screen flagged DCP1B as an isoform-selective GSK-3α associate, raising the possibility of links between decapping and kinase signaling.

    Evidence AP-MS and BioID proximity labeling in HEK293 and HeLa cells with reciprocal interaction assessment

    PMID:36779422

    Open questions at the time
    • Proximity labeling does not establish direct binding and reciprocal validation was not detailed
    • Functional consequence of any DCP1B–GSK-3α association is unknown

Open questions

Synthesis pass · forward-looking unresolved questions
  • The direct endogenous mRNA substrates of DCP1B and the molecular basis of its selectivity over DCP1a remain undefined.
  • No genome-wide direct-substrate map for DCP1B
  • Structural mechanism of EVH1-mediated DCP2 enhancement unresolved
  • Identity of the protein-degradation/translational partners distinguishing DCP1B from DCP1a not established

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 2 GO:0098772 molecular function regulator activity 2
Localization
GO:0005829 cytosol 1
Pathway
R-HSA-8953854 Metabolism of RNA 2
Partners
Complex memberships
mRNA decapping complex

Evidence

Reading pass · 5 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2024 Human DCP1b is a cofactor of the mRNA decapping enzyme DCP2; the EVH1 domain of DCP1 enhances the mRNA-binding affinity of DCP2. DCP1b knockout cells show distinct transcriptome and metabolome changes compared to DCP1a knockouts, demonstrating paralog-specific regulation of endogenous mRNA targets and biological processes. DCP1a/DCP1b knockout cell lines, transcriptome analysis, metabolome analysis, biochemical characterization of EVH1 domain function eLife High 39485278
2024 DCP1b is a non-redundant cofactor of DCP2 with a unique role in decapping complex interactions with protein degradation and translational machinery, distinct from DCP1a which is required for decapping complex assembly and interactions with mRNA cap-binding proteins. DCP1a and DCP1b regulate turnover of distinct sets of mRNAs. Functional dissection using DCP1a and DCP1b knockdown/knockout, decapping complex interaction assays, mRNA turnover analysis Life science alliance High 39256052
2025 p53 transcriptionally activates DCP1B expression. DCP1B promotes the turnover of MAPK4 mRNA, thereby reducing MAPK4 protein levels. Reduced MAPK4 suppresses AKT phosphorylation independent of PI3K, sensitizing NSCLC cells to PI3K inhibitors. DCP1B overexpression inhibits NSCLC cell growth and migration. p53 transcriptional activation assays, DCP1B overexpression/knockdown, mRNA decay assays for MAPK4, AKT phosphorylation assays, in vitro and in vivo proliferation assays Cell death and differentiation Medium 40200093
2024 DCP1b localizes to processing bodies (P-bodies), which contain RNA decay machinery. During West Nile, Zika, or dengue virus infection, sfRNAs accumulate in P-bodies containing DCP1b, but upon RNase L activation sfRNAs re-localize away from P-bodies (including DCP1b-containing structures) to RNase L-induced bodies, coinciding with increased viral RNA decay. Single-molecule RNA fluorescence in situ hybridization (smRNA-FISH), co-localization imaging of DCP1b with viral sfRNAs during infection Cell reports Medium 39196777
2023 DCP1B was identified as a proximity interactor of GSK-3α (preferentially over GSK-3β) by BioID proximity-dependent biotinylation mass spectrometry, and reciprocal interaction was evaluated, suggesting DCP1B associates with the GSK-3α isoform. Affinity purification mass spectrometry and BioID proximity labeling in HEK293 and HeLa cells, reciprocal interaction assessment Journal of proteome research Low 36779422

Source papers

Stage 0 corpus · 16 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2023 Microvascular and macrovascular complications of type 2 diabetes mellitus: Exome wide association analyses. Frontiers in endocrinology 71 37033211
2019 Integrative Analysis of Transcriptome and GWAS Data to Identify the Hub Genes Associated With Milk Yield Trait in Buffalo. Frontiers in genetics 55 30804981
2014 MicroRNA-138 is a potential regulator of memory performance in humans. Frontiers in human neuroscience 53 25071529
2014 Dysregulated expression of lipid storage and membrane dynamics factors in Tia1 knockout mouse nervous tissue. Neurogenetics 41 24659297
2010 1.39 Mb inherited interstitial deletion in 12p13.33 associated with developmental delay. European journal of medical genetics 26 21144913
2024 RNase L-induced bodies sequester subgenomic flavivirus RNAs to promote viral RNA decay. Cell reports 15 39196777
2023 Interactomes of Glycogen Synthase Kinase-3 Isoforms. Journal of proteome research 12 36779422
2025 p53 transcriptionally activates DCP1B to suppress tumor progression and enhance tumor sensitivity to PI3K blockade in non-small cell lung cancer. Cell death and differentiation 4 40200093
2023 Candidate biomarkers and persistent transcriptional responses after low and high dose ionizing radiation at high dose rate. International journal of radiation biology 4 37549410
2024 Human DCP1 is crucial for mRNA decapping and possesses paralog-specific gene regulating functions. eLife 3 39485278
2025 Genome-Wide and Rare Variant Association Studies of Amblyopia in the All of Us Research Program. Ophthalmology 2 39842729
2024 Non-redundant roles for the human mRNA decapping cofactor paralogs DCP1a and DCP1b. Life science alliance 2 39256052
2026 Plasma proteome mendelian randomization and network pharmacology reveal therapeutic targets for thyroid disorders. Molecular and cellular endocrinology 0 41616832
2026 Rare coding variation and stroke heterogeneity in Saudi Arabia: an exome‑wide association study across severity, etiology, vascular territory, and early‑onset disease. BMC neurology 0 42087103
2025 Genomic relationship between polycystic ovary syndrome and bipolar disorder. Research square 0 41041534
2024 Identification and Functional Analysis of Ras-Related Associated with Diabetes Gene (rrad) in Edwardsiella piscicida-Resistant Individuals of Japanese Flounder (Paralichthys olivaceus). International journal of molecular sciences 0 39408905

Missed literature

Know a paper Affinage missed for DCP1B? Flag it for the maintainers and the community.

No submissions yet.